York Region COVID-19 Guidance

Ministry of Health 

Public Health Agency of Canada

Other

Centers for Disease Control and Prevention (CDC)

European Centre for Disease Prevention and Control

Public Health England

• How to take a combined nose and throat swab for COVID-19 

• How to use a nose swab kit to test for COVID-19 - a guide for social care staff in all settings 

World Health Organization

Other 

• CEBM. Comparative accuracy of oropharyngeal and nasopharyngeal swabs for diagnosis of COVID-19 

• CEBM. In patients of COVID-19, what are the symptoms and clinical features of mild and moderate cases (Apr 1) 

• CEBM. NEWS (or NEWS2) score when assessing possible COVID-19 patients in primary care? 

• CEBM. Sniffing out the evidence for olfactory symptoms as a clinical feature of COVID-19: A Systematic Scoping Review   

• CEBM. What tests could potentially be used for the screening, diagnosis and monitoring of COVID-19 and what are their advantages and disadvantages? 
• Cochrane. Diagnosis of SARS-CoV-2 infection and COVID-19: accuracy of signs and symptoms; molecular, antigen, and antibody tests; and routine laboratory markers (Protocol) 
• ECRI. Position Paper: Prudent use of SARS-CoV-2 antibody testing: Avoiding false assumptions (Apr 13) 

• FDA. Everlywell COVID-19 Test Home Collection Kit (May 15) 

• FDA. Fact sheet for healthcare providers: ScienCell™ SARS-CoV-2 Coronavirus Real-time RT-PCR (RT-qPCR) Detection Kit (Apr 3) 

• FDA. Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised) (May 4) 
• Mayo Clinic. Coronavirus disease 2019 (COVID-19) 

• MMWR. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020 (Jul 24)

• Johns Hopkins. At-Home diagnostic testing for infectious diseases: a tool for accelerating COVID-19 diagnosis and building pandemic preparedness for the future (Jun 2020)

• Eurosurveillance. Strong associations and moderate predictive value of early symptoms for SARS-CoV-2 test positivity among healthcare workers, the Netherlands, March 2020 

• Health Information and Quality Authority. Evidence summary of immunity response following infection with COVID-19 (May 13) 

• Health Information and Quality Authority. Evidence summary of the infectiousness of individuals reinfected with SARS-CoV-2 or other human coronaviruses (May 3) 

• Health Information and Quality Authority. Evidence summary for COVID-19 viral load over course of infection (Apr 1) 
• Imperial College. Report 8: Symptom progression of COVID-19 (Mar 11) 
• Imperial College. Report 16: Role of testing in COIVD-19 control (Apr 23)

York Region Public Health